This study is being done to understand the decision-making process regarding management choice in low-risk papillary thyroid cancer.

Inclusion Criteria:

• Able to read, write, and communicate in English Patients who have been diagnosed with LR-PTC as described above
• For Aim 1, adults with recently diagnosed LR-PTC who have not yet made a choice between surgery and AS
• For Aim 2, adults with LR-PTC who made a decision about surgery or AS at least 3 months prior, but no more than 4 years prior to their routine follow-up visit at which they are being recruited for this study.
• Active patients of MSK and participating institutions

Exclusion Criteria:

• Patients who have been diagnosed with a tumor greater than 2 cm
• Patients with clinically suspicious lymphadenopathy in the neck
• Patients with evidence of gross ETE after a biopsy of the papillary thyroid tumor

The study will be conducted primarily in the MSK endocrinology and surgery clinics, which have a large volume of patients with LR-PTC choosing both surgery and AS. We also expect to expand this study to several clinics within the MSK Alliance Network and outside participating sites.